Device Trial Radar · NCT00235157
A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.
Last checked: Nov 20, 2026Latest source record: Aug 6, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
105
Actual
Start
Nov 2001
Primary completion
Nov 2002
Study completion Jul 2005
Sponsor
- Lead sponsor
- Cordis US Corp.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 10, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare the safety and performance of the Palmaz Genesis™ balloon expandable stent, with or without sirolimus coating in the treatment of renal artery stenosis, measured at 6 months follow up via angiography.
Conditions
- Renal Artery Stenosis
Interventions
Sirolimus-eluting Palmaz Genesis peripheral stentDevice
treatment of renal artery stenosis with a renal stent
Primary outcomes
What the sponsor says the trial is designed to measure.
- assessment of the angiographical in-stent minimal lumen diameterTime frame: 6-months follow up
Locations
3 sites in 3 countries. Site status is shown where the registry gives one.
Hopital Européen Georges Pompidou
Paris, France
Universitätskliniken Köln
Cologne, Germany
Erasmus MC Rotterdam
Rotterdam, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.